Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6185 of 6351
-
Dietary energy restriction tested to reverse prediabetes – study withdrawn
Disease control CancelledThis study aims to evaluate the preliminary efficacy of a low-calorie diet (LCD) intervention in addressing the underlying pathophysiological abnormalities and improving fasting hyperglycemia among individuals with isolated impaired fasting glucose (i-IFG). Additionally, it seeks…
Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
HIIT for blood sugar: study withdrawn before it started
Knowledge-focused CancelledThis pilot randomized controlled trial will involve 34 physically inactive adults aged 35-65 years with overweight or obesity and isolated impaired fasting glucose (i-IFG). The study aims to assess the feasibility of recruiting and retaining participants, implementing study proce…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Botox during prostate surgery: a promising combo that never got tested
Symptom relief CancelledBenign prostatic hyperplasia (BPH) is the most common benign neoplasm in men. Almost 90% of men in their 70s report lower urinary tract symptoms related to BPH. These symptoms carry a significant negative impact on the patients' quality of life. Despite the wide availability of …
Phase 4 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jun 26, 2026 14:23 UTC
-
Suicide prevention study pulled before starting
Knowledge-focused CancelledThe suicide rate has increased 28% over the past two decades while heart disease, diabetes, and cancer mortality has declined. Starting in 2011, new standards have led to improved adoption and reach of suicide risk surveillance in primary and specialty care. Treatment, however, h…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Asthma inhaler showdown: new combo vs. standard care
Disease control CancelledEurofarma Laboratórios S.A. markets a FDC containing formoterol 12 mcg/fluticasone 250 mcg, in a single capsule for inhalation (Lugano®; reference product). The product is indicated for the treatment of asthma in patients aged ≥ 12 years. The company seeks to register a product w…
Phase 3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New eye scanner aims to spot early signs of disease
Knowledge-focused Not yet recruitingThe aim of this pilot study is to assess the ability of a new polarization sensitive optical coherence tomography system to obtain high-quality images of retinal birefringence.
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Pain relief study for smokers after lung surgery pulled before it started
Symptom relief CancelledThis randomized, double-blind, controlled clinical trial evaluates whether adding dexmedetomidine to an oliceridine-based patient-controlled intravenous analgesia (PCIA) regimen can improve postoperative pain control and tolerability after video-assisted thoracoscopic lobectomy i…
Phase 4 • Sponsor: Shenyang Sixth People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New breast PET camera aims for sharper images, but study never started
Knowledge-focused CancelledThis is a research study of a novel, "breast-dedicated" positron emission tomography (PET) camera with 1 millimeter spatial resolution. The main goal of the study is for the personnel to understand practical and logistical issues with using the camera in the clinic
Early phase 1 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Healthy volunteers needed to test how breakfast changes drug absorption
Knowledge-focused Not yet recruitingThis study is a randomized, open-label, 2-period, 2-sequence, crossover food-effect study designed to evaluate the effect of a high-fat meal on the pharmacokinetics of a single oral dose of KH607 tablets in healthy participants, as well as to assess the safety of a single oral do…
Phase 1 • Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Healthy volunteers needed to test new version of cancer drug
Knowledge-focused Not yet recruitingThis study is a single-center, single-dose, randomized, open-label, two-period, crossover phase I clinical trial, comparing the bioavailability and safety of the new and old processes of HRS-2189 tablets in healthy subjects.
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Abandoned trial: drug for Treatment-Related anemia never tested
Disease control CancelledThis study aimed to explore the efficacy and safety of romiplostim N01 in the treatment of relapsed/refractory chemoradiotherapy-induced aplastic anemia
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Apple watch study to track CRPS pain triggers in kids cancelled
Knowledge-focused Cancelledobjectives: identify physiologic, dietary, and environment triggers of severe pain exacerbations in children with CRPS.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Healthy volunteers needed to map aortic blood flow with Cutting-Edge MRI
Knowledge-focused Recruiting nowThis study aims to gain insights into aortic blood flow in healthy volunteers using PC 4D-flow MRI
Sponsor: University of Twente • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New combo pill for cholesterol and blood pressure put to the test
Knowledge-focused Not yet recruitingA Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C
Phase 1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Zapped nerves: study planned to boost recovery after surgery — but never started
Knowledge-focused CancelledThe purpose of this research study is to find out if using direct electrical stimulation during surgery is safe and helpful for people with nerve problems caused by compressed nerves.
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug SSS68 tested in healthy people for first time
Knowledge-focused Not yet recruitingThis is a randomized, double-blind, placebo-controlled, single ascending dose phase I clinical study to evaluate the safety, tolerability, PK, PD and immunogenicity of SSS68 in healthy adult participants following a single subcutaneous administration.
Phase 1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
AI coaching boosts student writing in new study
Knowledge-focused Not yet recruitingThis randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students. A total of 102 students enrolled in an academic …
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug KR25102 tested in healthy people for first time
Knowledge-focused Not yet recruitingPhase 1 Single Ascending Doses(SAD): Six cohorts of 53 healthy volunteers (HVs) will receive a single IV bolus injection of study drug or placebo. Phase 1 Multiple Ascending Doses(MAD): Three cohorts of 30 HVs will receive multiple IV bolus injections of study drug or placebo ev…
Phase 1 • Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug CIT-013 tested for safety in small human trial
Knowledge-focused Not yet recruitingThis is a phase 1, double-blind, randomized, placebo-controlled, single center, repeat-dose trial for the assessment of safety, tolerability, bioavailability and pharmacokinetic profiles of 150 mg CIT-013 in healthy adult volunteers
Phase 1 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
First human test: can a new drug called ADB116 be given safely?
Knowledge-focused Recruiting nowA Phase I Study of ADB116 for Injection in Healthy Chinese Adults. This study aims as follows: Primary Objective: • To evaluate the safety and tolerability of a single intravenous bolus dose of ADB116 for injection in healthy Chinese adults. Secondary Objective: • To evaluate…
Phase 1 • Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC